You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 20, November 12, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Stroke
 •Arrhythmias
 •Thrombolysis
 •Alert me on articles by topic

Prevalence and Quality of Warfarin Use for Patients With Atrial Fibrillation in the Long-term Care Setting

Danny McCormick, MD, MPH; Jerry H. Gurwitz, MD; Robert J. Goldberg, PhD; Richard Becker, MD; Janet P. Tate, MPH; Anne Elwell, RN; Martha J. Radford, MD

Arch Intern Med. 2001;161:2458-2463.

Background  Evidence-based clinical practice guidelines recommend the use of warfarin sodium for stroke prevention in most patients with atrial fibrillation (AF) who do not have risk factors for hemorrhagic complications, irrespective of age.

Methods  The medical records of all residents of a convenience sample of long-term care facilities in Connecticut (n = 21) were reviewed. The percentages of all patients with AF (AF patients) and ideal candidates for warfarin therapy (ie, AF patients with no risk factors for hemorrhage) who received warfarin were determined; for patients receiving warfarin, the percentage of days spent in the therapeutic range of international normalized ratio (INR) values (2.0-3.0) was also assessed. The relationship between receipt of warfarin and the presence of stroke and bleeding risk factors was assessed in multivariate models.

Results  Atrial fibrillation was present in 429 (17%) of the 2587 long-term care residents. Overall, 42% of AF patients were receiving warfarin. However, only 44 (53%) of 83 ideal candidates were receiving this therapy. In residents who received warfarin therapy, the therapeutic range of INR values was maintained only 51% of the time. The odds of receiving warfarin in the study sample decreased with increasing number of risk factors for bleeding and increased (nonsignificant trend) with increasing number of stroke risk factors present.

Conclusions  Atrial fibrillation is very common among residents of long-term care facilities. Even among apparently ideal candidates, warfarin therapy is underused for stroke prevention in patients with AF. Prescribing decisions and monitoring related to warfarin therapy in the long-term care setting warrant improvement.


From the Department of Medicine, Cambridge Hospital, Cambridge, Mass, and Harvard Medical School, Boston, Mass (Dr McCormick); Meyers Primary Care Institute (Drs Gurwitz and Goldberg) and the Department of Cardiology (Drs Goldberg and Becker), University of Massachusetts Medical School, Worcester; the Fallon Healthcare System, Worcester (Drs Gurwitz and Goldberg); Qualidigm Inc, Middletown, Conn (Mss Tate and Elwell and Dr Radford); and the Yale Health System, New Haven, Conn (Dr Radford).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality of Clinical Documentation and Anticoagulation Control in Patients With Chronic Nonvalvular Atrial Fibrillation in Routine Medical Care
Ansell et al.
American Journal of Medical Quality 2007;22:327-333.
ABSTRACT  

Trends in Anticoagulation for Atrial Fibrillation in the U.S.: An Analysis of the National Ambulatory Medical Care Survey Database
Rowan et al.
J Am Coll Cardiol 2007;49:1561-1565.
ABSTRACT | FULL TEXT  

Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Friberg et al.
Eur Heart J 2006;27:1954-1964.
ABSTRACT | FULL TEXT  

Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression
van Walraven et al.
Chest 2006;129:1155-1166.
ABSTRACT | FULL TEXT  

Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
Birman-Deych et al.
Stroke 2006;37:1070-1074.
ABSTRACT | FULL TEXT  

Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
Waldo et al.
J Am Coll Cardiol 2005;46:1729-1736.
ABSTRACT | FULL TEXT  

A Preliminary Assessment of the Critical Differences Between Novel Oral Anticoagulants Currently in Development
McBride
J Clin Pharmacol 2005;45:1004-1017.
ABSTRACT | FULL TEXT  

Prognostic Implications of Warfarin Cessation After Major Trauma: A Population-Based Cohort Analysis
Hackam et al.
Circulation 2005;111:2250-2256.
ABSTRACT | FULL TEXT  

A Community-Based Educational Intervention to Improve Antithrombotic Drug Use in Atrial Fibrillation
Jackson et al.
The Annals of Pharmacotherapy 2004;38:1794-1799.
ABSTRACT | FULL TEXT  

Medication Undertreatment in Assisted Living Settings
Sloane et al.
Arch Intern Med 2004;164:2031-2037.
ABSTRACT | FULL TEXT  

Safety of Anticoagulation Therapy in Well-informed Older Patients
Kagansky et al.
Arch Intern Med 2004;164:2044-2050.
ABSTRACT | FULL TEXT  

Improving Medication Use for Older Adults: An Integrated Research Agenda
Murray and Callahan
ANN INTERN MED 2003;139:425-429.
ABSTRACT | FULL TEXT  

Editorial: Hot Topics in Geriatrics
Morley
J. Gerontol. A Biol. Sci. Med. Sci. 2003;58:M30-36.
FULL TEXT  

Improving the Quality of Medication Use in Elderly Patients: A Not-So-Simple Prescription
Gurwitz and Rochon
Arch Intern Med 2002;162:1670-1672.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.